Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid × Deferasirox × Clear all

Sponsor

Conditions

Multiple Myeloma 3 Leukemia, Myeloid, Acute 3 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Iron Overload 2 Hodgkin Disease 2 Congenital Abnormalities 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Testicular Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

Imatinib Mesylate 5 ponatinib 4 Cytarabine 4 venetoclax 3 nilotinib 3 Mycophenolic Acid 3 thymoglobulin 2 fludarabine phosphate 2 Lenalidomide 2 Cyclosporine 2 Cyclophosphamide 2 Antilymphocyte Serum 2 quizartinib 1 methanesulfonic acid 1 glasdegib 1 fludarabine 1 etoposide phosphate 1 enasidenib 1 daratumumab 1 bosutinib 1 asciminib 1 Whole-Body Irradiation 1 Transplantation 1 Temozolomide 1 Tacrolimus 1 Stem Cell Transplantation 1 Standard of Care 1 RFT5-SMPT-dgA immunotoxin 1 Peripheral Blood Stem Cell Transplantation 1 N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡